Explore company profiles, quarterly results, announcements and ownership disclosures.
Loading the company view…
Hemant Surgical Industries Ltd (NSE: HSIL), ISIN INE0GYI01028 — earnings, PEAD surprise, concall summary, Walk-the-Talk management consistency, SAST and insider filings, and the EquiSense Score (ECS), all in plain English on EquiSense.
HSIL last traded at ₹598.00 (-2.77%), with a 52-week range of ₹215.00 to ₹616.50 (as of 23 Sep 2026).
Shareholding as of Mar 2026: promoters 58.90%, FIIs 0.15%, DIIs 10.73%, mutual funds 0.00%.
EquiSense Score (ECS): 73/100.
Data sourced from NSE and BSE filings. Educational — not investment advice.